MAY 28-29, 2022


Corneal Confocal Microscopy: a Surrogate Endpoint for Neurodegeneration in Clinical Trials

Solomon Tesfaye, MB ChB, MD, FRCP

Solomon Tesfaye

Research Director, Academic Directorate of Diabetes & Endocrinology
Sheffield Teaching Hospitals and the University of Sheffield Royal Hallamshire Hospital
Sheffield, UK

 

Solomon Tesfaye is a Consultant Physician/Endocrinologist at Sheffield Teaching Hospitals and Honorary Professor of Diabetic Medicine at the University of Sheffield. He is also Visiting Professor at Shanghai Jiao Tong University and Adjunct Professor at Xiangya Hospital Central Southern University, China.His research projects include the epidemiology, risk factors, pathogenesis, central nervous system involvement and treatment of diabetic neuropathy and neuropathic pain. He has published a book, over 200 original articles and reviews in diabetic neuropathy including a landmark study in the NEJM.Professor Tesfaye was awarded the Prestigious Camillo Golgi Prize of the European Diabetes Association in 2014 for major scientific contributions in Diabetic Neuropathy. He also received the Arnold Bloom Award of Diabetes UK in 2017 for innovative and patient-centered diabetes care; and the NHS Innovations National Award for One Stop Diabetes Screening Service in 2021. Prof Tesfaye served as Chair the International Expert Group on Diabetic Neuropathy 2010/11; and of NEURODIAB (2006-9) which is the largest diabetic neuropathy scientific group in the world. He is currently a member of the Diabetes UK Research Steering Group for diabetic complications. He is also an Associate Editor of Experimental Diabetes Research, Frontiers in Endocrinology, European Endocrinology and Diabetes Management and previously of Diabetologia and the Lancet Diabetes and Endocrinology. Professor Tesfaye also serves as grant review panel member for the JDRF, US NIH, Diabetes UK, UK NIHR, EFSD, MRC, Welcome Trust; and has been a member of 3 NICE guideline committees on neuropathic pain management and DPFS panel of the MRC. Finally, he has received several research grants including: 5 project grants from Diabetes UK, JDRF, NIH, EFSD, NIHR and a recent £2.97m UK HTA award to investigate the most effective treatment pathway for painful diabetic neuropathy.

Co-Sponsors